Last 12 months
Inside the activity.
0 purchase rows · 27 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 26, 2024 Filed Apr 30, 2024 07:49 UTC |
Ryan Robert John AndrewDirector
|
PurchaseCommon Stock | 5,000 | $3.48 | $17,400.00 |
DisclosureSEC source: 0001477932-24-002403 · form4.xml · nonDerivative · entry 1 Ryan Robert John Andrew · CIK 0002011790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 551,555 F1 · price: Open market purchase transaction. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 21:04 UTC |
Ryan Robert John AndrewDirector
|
PurchaseCommon Stock | 2,000 | $3.40 | $6,800.00 |
DisclosureSEC source: 0001477932-24-002397 · form4.xml · nonDerivative · entry 3 Ryan Robert John Andrew · CIK 0002011790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 546,555 F1 · price: Open market purchase transactions. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 21:04 UTC |
Ryan Robert John AndrewDirector
|
PurchaseCommon Stock | 2,500 | $3.46 | $8,650.00 |
DisclosureSEC source: 0001477932-24-002397 · form4.xml · nonDerivative · entry 2 Ryan Robert John Andrew · CIK 0002011790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 544,555 F1 · price: Open market purchase transactions. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 21:04 UTC |
Ryan Robert John AndrewDirector
|
PurchaseCommon Stock | 5,000 | $3.40 | $17,000.00 |
DisclosureSEC source: 0001477932-24-002397 · form4.xml · nonDerivative · entry 1 Ryan Robert John Andrew · CIK 0002011790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 542,055 F1 · price: Open market purchase transactions. Read SEC document |
| January 29, 2024 Filed Feb 26, 2024 07:27 UTC |
Ryan Robert John AndrewDirector
|
PurchaseCommon Stock | 15,596 | $2.35 | $36,650.60 |
DisclosureSEC source: 0001477932-24-000885 · primary_doc.xml · nonDerivative · entry 5 Ryan Robert John Andrew · CIK 0002011790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 537,055 F2 · price: Open market purchase transactions. Read SEC document |
| January 25, 2024 Filed Feb 26, 2024 07:27 UTC |
Ryan Robert John AndrewDirector
|
PurchaseCommon Stock | 100 | $2.54 | $254.00 |
DisclosureSEC source: 0001477932-24-000885 · primary_doc.xml · nonDerivative · entry 4 Ryan Robert John Andrew · CIK 0002011790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 521,459 F2 · price: Open market purchase transactions. Read SEC document |
| January 17, 2024 Filed Feb 26, 2024 07:27 UTC |
Ryan Robert John AndrewDirector
|
PurchaseCommon Stock | 100 | $1.91 | $191.00 |
DisclosureSEC source: 0001477932-24-000885 · primary_doc.xml · nonDerivative · entry 3 Ryan Robert John Andrew · CIK 0002011790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 521,359 F2 · price: Open market purchase transactions. Read SEC document |
| January 16, 2024 Filed Feb 26, 2024 07:27 UTC |
Ryan Robert John AndrewDirector
|
PurchaseCommon Stock | 2,550 | $1.92 | $4,896.00 |
DisclosureSEC source: 0001477932-24-000885 · primary_doc.xml · nonDerivative · entry 2 Ryan Robert John Andrew · CIK 0002011790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 521,259 F2 · price: Open market purchase transactions. Read SEC document |
| January 14, 2024 Filed Feb 26, 2024 07:27 UTC |
Ryan Robert John AndrewDirector
|
GrantCommon Stock | 50,251 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477932-24-000885 · primary_doc.xml · nonDerivative · entry 1 Ryan Robert John Andrew · CIK 0002011790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 518,709 F1 · date: This award of common stock with a market value of $100,000 on January 14, 2024 was made in connection with the appointment of Mr. Ryan to the board of directors effective January 14, 2024, as previously disclosed in the issuer's Form 8-K filed on January 18, 2024. F1 · price: This award of common stock with a market value of $100,000 on January 14, 2024 was made in connection with the appointment of Mr. Ryan to the board of directors effective January 14, 2024, as previously disclosed in the issuer's Form 8-K filed on January 18, 2024. Read SEC document |
| October 26, 2023 Filed Oct 31, 2023 01:51 UTC |
Wider ToddDirector
|
PurchaseCommon Stock | 94,844 | $0.96 | $91,050.24 |
DisclosureSEC source: 0001477932-23-007983 · form4.xml · nonDerivative · entry 1 Wider Todd · CIK 0001642715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 494,844 F1 · deemedExecutionDate: Shares of the Issuer's Common Stock were purchased in the Issuer's private placement of Common pursuant to a Securities Purchase Agreement, dated October 9, 2023, by and among the Issuer and the other purchasers named therein. The shares of Common Stock acquired were purchased at a price per share of $0.96 per share of Common Stock (the consolidated closing bid price per share immediately preceding the signing of the binding agreement to issue the securities). Read SEC document |
| October 26, 2023 Filed Oct 30, 2023 21:50 UTC |
Donfeld Joshua JayDirector
|
PurchaseCommon Stock | 104,167 | $0.96 | $100,000.32 |
DisclosureSEC source: 0001477932-23-007982 · form4.xml · nonDerivative · entry 1 Donfeld Joshua Jay · CIK 0001870347 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,104,167 F1 · deemedExecutionDate: Shares of the Issuer's Common Stock were purchased in the Issuer's private placement of Common pursuant to a Securities Purchase Agreement, dated October 9, 2023, by and among the Issuer and the other purchasers named therein. The shares of Common Stock acquired were purchased at a price per share of $0.96 per share of Common Stock (the consolidated closing bid price per share immediately preceding the signing of the binding agreement to issue the securities). Read SEC document |
| October 26, 2023 Filed Oct 31, 2023 01:51 UTC |
Moore DuncanDirector
|
PurchaseCommon Stock | 104,167 | $0.96 | $100,000.32 |
DisclosureSEC source: 0001477932-23-007984 · form4.xml · nonDerivative · entry 2 Moore Duncan · CIK 0001888265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 854,167 F2 · deemedExecutionDate: Shares of the Issuer's Common Stock were purchased in the Issuer's private placement of Common pursuant to a Securities Purchase Agreement, dated October 9, 2023, by and among the Issuer and the other purchasers named therein. The shares of Common Stock acquired were purchased at a price of $0.96 per share of Common Stock (the consolidated closing bid price per share immediately preceding the signing of the binding agreement to issue the securities). Read SEC document |
| October 23, 2023 Filed Feb 26, 2024 12:10 UTC |
Gorley MichaelDirector
|
GrantCommon Stock | 93,458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477932-24-000883 · primary_doc.xml · nonDerivative · entry 1 Gorley Michael · CIK 0002012446 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,458 F1 · date: This award of common stock with a market value of $100,000 on October 23, 2023 was made in connection with the appointment of Mr. Gorley to the board of directors effective October 23, 2023, as previously disclosed in the issuer's Form 8-K filed on October 23, 2023. F1 · price: This award of common stock with a market value of $100,000 on October 23, 2023 was made in connection with the appointment of Mr. Gorley to the board of directors effective October 23, 2023, as previously disclosed in the issuer's Form 8-K filed on October 23, 2023. Read SEC document |
| August 10, 2023 Filed Oct 31, 2023 01:51 UTC |
Moore DuncanDirector
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-23-007984 · form4.xml · nonDerivative · entry 1 Moore Duncan · CIK 0001888265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,000 F1 · deemedExecutionDate: This special one-time equity award of 200,000 restricted shares was made in connection with the appointment of Mr. Moore to the Special Projects Committee of the board of Directors. Mr. Moore will vest in four equal installments every six months. Read SEC document |
| June 29, 2023 Filed Jul 3, 2023 11:04 UTC |
Moore DuncanDirector
|
PurchaseCommon Stock | 50,000 | $0.50 | $24,995.00 |
DisclosureSEC source: 0001477932-23-004971 · form4.xml · nonDerivative · entry 2 Moore Duncan · CIK 0001888265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 550,000 Read SEC document |
| June 29, 2023 Filed Jul 3, 2023 11:04 UTC |
Moore DuncanDirector
|
PurchaseCommon Stock | 50,000 | $0.50 | $24,995.00 |
DisclosureSEC source: 0001477932-23-004971 · form4.xml · nonDerivative · entry 1 Moore Duncan · CIK 0001888265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:05 UTC |
Moore DuncanDirector
|
PurchaseCommon Stock | 20,000 | $0.31 | $6,230.00 |
DisclosureSEC source: 0001477932-23-003780 · form4.xml · nonDerivative · entry 1 Moore Duncan · CIK 0001888265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,000 Read SEC document |
| May 10, 2023 Filed May 16, 2023 12:09 UTC |
Moore DuncanDirector
|
PurchaseCommon Stock | 10,000 | $0.50 | $5,000.00 |
DisclosureSEC source: 0001477932-23-003621 · form4.xml · nonDerivative · entry 1 Moore Duncan · CIK 0001888265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,000 Read SEC document |
| April 06, 2023 Filed Apr 11, 2023 14:50 UTC |
Moore DuncanDirector
|
PurchaseCommon Stock | 20,000 | $1.00 | $19,998.00 |
DisclosureSEC source: 0001477932-23-002397 · form4.xml · nonDerivative · entry 1 Moore Duncan · CIK 0001888265 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,000 Read SEC document |
| March 01, 2023 Filed Mar 8, 2023 16:05 UTC |
Vasnetsov SergeyDirector
|
GrantCommon Stock | 538,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-23-001370 · form4.xml · nonDerivative · entry 1 Vasnetsov Sergey · CIK 0001500294 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,838,607 F1 · deemedExecutionDate: On March 1, 2023, the Company granted 538,607 shares of the Company's restricted common stock to ChemBridges LLC, a Puerto Rico limited liability company controlled by our director, Sergey Vasnetsov, as its manager, pursuant to a second amended Advisory Agreement dated December 12, 2022. 134,651 shares of the common stock vest on each June 1, 2023, September 1, 2023, December 1, 2023 and March 1, 2024. F2 · ownership.nature: Mr. Vasnetsov beneficially owns 1,000,000 common shares indiretly through Elista LLC and beneficially owns 2,838,607 common shares and indirectly through ChemBridges LLC. Read SEC document |
| March 01, 2023 Filed Mar 8, 2023 21:05 UTC |
Mann Paul ElliotDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 718,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-23-001369 · form4.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,805,643 F1 · deemedExecutionDate: On March 1, 2023, the Company granted 718,143 shares of the Company's restricted common stock to Paul Mann pursuant to an amended Employment Agreement dated December 20, 2022. 179,536 shares of the common stock vest on each June 1, 2023, September 1, 2023, December 1, 2023 and March 1, 2024. Read SEC document |
| December 30, 2022 Filed Feb 17, 2023 17:14 UTC |
Mann Paul ElliotDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-23-001110 · primary_doc.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,087,500 F1 · deemedExecutionDate: On December 30, 2022, the Company issued 1,000,000 shares of the Company's restricted common stock to Paul Mann as a bonus for services provided during the fiscal year ended December 31, 2022. Read SEC document |
| December 30, 2022 Filed Feb 17, 2023 17:16 UTC |
Ainscow RobertChief Financial Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-23-001111 · primary_doc.xml · nonDerivative · entry 1 Ainscow Robert · CIK 0001951275 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,000 F1 · deemedExecutionDate: On December 30, 2022, the Company issued 50,000 shares of the Company's restricted common stock to Robert Ainscow as a bonus for services provided during the fiscal year ended December 31, 2022. Read SEC document |
| December 30, 2022 Filed Feb 22, 2023 09:58 UTC |
Vasnetsov SergeyDirector
|
GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-23-001191 · form4.xml · nonDerivative · entry 1 Vasnetsov Sergey · CIK 0001500294 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,300,000 F1 · deemedExecutionDate: On December 30, 2022, the Company issued a bonus of 500,000 shares of the Company's restricted common stock to Sergey Vasnetsov, our director, for services provided during the fiscal year ended December 31, 2022 by ChemBridges LLC ("ChemBridge") a Puerto Rico limited liability company controlled by Sergey Vasnetsov as its manager. 125,000 shares of the common stock vest on each March 30, 2023, June 30, 2023, September 30, 2023 and December 30, 2023. F2 · ownership.nature: Mr. Vasnetsov beneficially owns 1,000,000 common shares indirectly through Elista LLC and beneficially owns 2,300,000 common shares indirectly through ChemBridges LLC. Read SEC document |
| November 15, 2022 Filed Nov 15, 2022 13:19 UTC |
Mann Paul ElliotDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-072582 · ownership.xml · nonDerivative · entry 2 Mann Paul Elliot · CIK 0001744816 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,087,500 F1 · deemedExecutionDate: This special one-time equity award of 1,000,000 restricted shares was contingent upon the completion of our IPO. Mr. Mann will receive 250,000 restricted shares of our common stock on November 15, 2023, 250,000 restricted shares of our common stock on November 15, 2024, 250,000 restricted shares of our common stock on November 15, 2025, and 250,000 shares of our restricted common stock on November 15, 2026. Read SEC document |
| November 15, 2022 Filed Nov 15, 2022 13:19 UTC |
Mann Paul ElliotDirector · Chief Executive Officer · 10% owner
|
GrantCommon Stock | 37,500 | $4.00 | $150,000.00 |
DisclosureSEC source: 0001213900-22-072582 · ownership.xml · nonDerivative · entry 1 Mann Paul Elliot · CIK 0001744816 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,087,500 Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 17:50 UTC |
Wider ToddDirector
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-073100 · ownership.xml · nonDerivative · entry 1 Wider Todd · CIK 0001642715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 F1 · deemedExecutionDate: This special one-time equity award of 200,000 restricted shares was contingent upon the completion of our IPO. Mr. Wider will receive 100,000 restricted shares of our common stock on November 15, 2023 and 100,000 restricted shares of our common stock on November 15, 2024. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 12:47 UTC |
Vasnetsov SergeyDirector
|
GrantCommon Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-073098 · ownership.xml · nonDerivative · entry 1 Vasnetsov Sergey · CIK 0001500294 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Foot note Disclosed balance after: 2,800,000 F1 · deemedExecutionDate: This special one-time equity award of 600,000 restricted shares were contingent upon the completion of our IPO. Mr. Vasnetsov will receive 150,000 restricted shares of our common stock on November 15, 2023, 150,000 restricted shares of our common stock on November 15, 2024, 150,000 restricted shares of our common stock on November 15, 2025, and 150,000 shares of our restricted common stock on November 15, 2026. F2 · ownership.nature: Mr. Vasnetsov beneficially owns 1,000,000 shares indirectly through Elista LLC and beneficially owns 1,800,000 shares indirectly through ChemBridges LLC. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 12:38 UTC |
Donfeld Joshua JayDirector
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-073089 · ownership.xml · nonDerivative · entry 1 Donfeld Joshua Jay · CIK 0001870347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 F1 · deemedExecutionDate: This special one-time equity award of 200,000 restricted shares was contingent upon the completion of our IPO. Mr. Donfeld will receive 100,000 restricted shares of our common stock on November 15, 2023 and 100,000 restricted shares of our common stock on November 15, 2024. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 17:41 UTC |
Moore DuncanDirector
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-073093 · ownership.xml · nonDerivative · entry 1 Moore Duncan · CIK 0001888265 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 F1 · deemedExecutionDate: This special one-time equity award of 200,000 restricted shares was contingent upon the completion of our IPO. Mr. Moore will receive 100,000 restricted shares of our common stock on November 15, 2023 and 100,000 restricted shares of our common stock on November 15, 2024. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 17:44 UTC |
Strydom HendrikDirector · 10% owner
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-073095 · ownership.xml · nonDerivative · entry 1 Strydom Hendrik · CIK 0001951278 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,797,423 F1 · deemedExecutionDate: The special one-time award of 200,000 restricted shares were contingent upon the completion of our IPO. Dr. Strydom will receive 100,000 restricted shares of our common stock on November 15, 2023 and 100,000 restricted shares of our common stock on November 15, 2024. F2 · ownership.nature: Dr. Strydom beneficially owns 3,797,423 shares indirectly through Tianne Holdings (Pty) Ltd. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 17:35 UTC |
Ainscow RobertChief Financial Officer
|
GrantCommon Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-073086 · ownership.xml · nonDerivative · entry 1 Ainscow Robert · CIK 0001951275 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850,000 F1 · deemedExecutionDate: This special one-time equity award of 600,000 restricted shares was contingent upon the completion of our IPO. Mr. Ainscow will receive 150,000 restricted shares of our common stock on November 15, 2023, 150,000 restricted shares of our common stock on November 15, 2024, 150,000 restricted shares of our common stock on November 15, 2025, and 150,000 shares of our restricted common stock on November 15, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.